You are here
- Home
- Last 30 days trials
A Phase I, Open-label, Multicentre, Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of AZD2014 Administered Orally in Combination With Intramuscular (IM) Fulvestrant to Patients With Estrogen Receptor Positive (ER+) Advanced, Metastatic Breast Cancer.
- Disease
- advanced breast cancer
- Generic Name
- AZD2014
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- I
- Start Date
- May 7, 2012
- Study Name
- D2270C00005
- Study Id
- D2270C00005
- ClinicalTrials.gov ID
- NCT01597388
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
